• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Stem Cells

Brainstorm adds UCal Irvine Medical Center to late-stage NurOwn trial

July 25, 2017 By Sarah Faulkner

BrainStorm Cell Therapeutics

Brainstorm Cell Therapeutics (NSDQ:BCLI) said today that it inked an agreement with the University of California Irvine Medical Center to enroll patients in the Phase III trial of its NurOwn mesenchymal stem cell-based platform for amyotrophic lateral sclerosis. This marks the third medical center to work with Brainstorm to enroll patients in the late-stage pivotal trial. […]

Filed Under: Clinical Trials, Featured, Regenerative Medicine, Stem Cells, Wall Street Beat Tagged With: Brainstorm Cell Therapeutics

Brainstorm Cell Therapeutics wins $16m grant for pivotal NurOwn ALS study

July 21, 2017 By Fink Densford

BrainStorm Cell Therapeutics

Brainstorm Cell Therapeutics (NSDQ:BCLI) said today it won a $16 million grant from the California Institute of Regenerative Medicine to engage in a phase 3 study of its NurOwn mesenchymal stem cell-based platform for treating amyotrophic lateral sclerosis. Brainstorm said it is in the advanced stages of planning a Phase 3 clinical trial investigating NurOwn for […]

Filed Under: Business/Financial News, Clinical Trials, Featured, Funding Roundup, Regenerative Medicine, Stem Cells, Wall Street Beat Tagged With: Brainstorm Cell Therapeutics

Study: Induced pluripotent stem cells could yield accurate models for vascular disease

June 19, 2017 By Sarah Faulkner

HemoShear Therapeutics

Smooth muscle and vascular endothelial cells induced from pluripotent stem cells could help model rare vascular diseases, according to a study published in Stem Cells Translational Medicine.  Vascular diseases are tricky to study because they are hard to model and human tissue samples are scarce. An appropriate model for real blood vessels could enable researchers to […]

Filed Under: Discovery, Featured, Research & Development, Stem Cells, Vascular Tagged With: hemosheartherapeutics

Gamida Cell lands $40m for late-stage NiCord trial

June 19, 2017 By Sarah Faulkner

Gamida Cell

Gamida Cell said today that it raised $40 million to support the ongoing Phase III trial of its NiCord cell graft and expand its in-house manufacturing capacity. The private financing was led by new investor Shavit Capital. VMS Investment Group and Israel Biotech Fund joined existing investor Novartis in the round, as well as Clal Biotechnology […]

Filed Under: Clinical Trials, Featured, Funding Roundup, Stem Cells Tagged With: Gamida Cell

Brainstorm lands $2.1m Israeli grant for NurOwn stem cell therapy

June 13, 2017 By Sarah Faulkner

BrainStorm Cell Therapeutics

Brainstorm Cell Therapeutics (NSDQ:BCLI) said today that it landed a $2.1 million grant from the Israel Innovation Authority. The funds are slated to support the development of Brainstorm’s NurOwn mesenchymal stem cell-based platform for the treatment of neurodegenerative diseases, including ALS. This is the 10th year that Brainstorm has won grant support from the Israeli office […]

Filed Under: Featured, Funding Roundup, Regenerative Medicine, Stem Cells, Wall Street Beat Tagged With: Brainstorm Cell Therapeutics

ViaCyte looks to cell replacement therapy to cure Type I diabetes

May 22, 2017 By Sarah Faulkner

ViaCyte

ViaCyte said today that it will begin clinical trials of its novel islet cell replacement therapy in development as a potential cure for Type I diabetes, after landing regulatory wins from the FDA and Health Canada. The company’s PEC-Direct candidate delivers stem cell-derived pancreatic progenitor cells in a device that is designed to enable direct […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Funding Roundup, Stem Cells Tagged With: Juvenile Diabetes Research Foundation (JDRF), ViaCyte, W.L. Gore

Engineered tissue could eliminate radiation for bone marrow transplants

May 15, 2017 By Danielle Kirsh

engineered bone tissue

University of California San Diego engineers have created artificial bone tissue that could eliminate the need for radiation before bone marrow transplants. Shyni Varghese, a bioengineering professor at UC San Diego Jacobs School of Engineering, led a team to develop a bone-like implant to eliminate the pre-treatment radiation that kills stem cells in a patient’s bone […]

Filed Under: Research & Development, Stem Cells Tagged With: bone marrow, bone marrow disease, medtech, University of California San Diego

Magenta raises $50m, inks partnership with Novartis for stem cell transplant drugs

May 2, 2017 By Sarah Faulkner

Magenta Therapeutics

Magenta Therapeutics said today that it closed a $50 million Series B round and licensed a clinical-stage program from Novartis (NYSE:NVS) to advance its stem cell transplantation platform. The company also inked a partnership deal with Be The Match BioTherapies. Google’s venture arm, GV, led the financing round and was joined by existing investors, including […]

Filed Under: Featured, Funding Roundup, Pharmaceuticals, Stem Cells, Wall Street Beat Tagged With: bethematchbiotherapies, magentatherapeutics, Novartis

Study: Gamida Cell’s NiCord cell graft yields fewer infections, shorter hospital stays

April 21, 2017 By Sarah Faulkner

Gamida Cell

Gamida Cell said today that its NiCord cell graft produces fewer infections, shorter hospital stays and shorter time to engraftment compared to standard umbilical cord blood transplantation. The company’s work was published in Biology of Blood and Marrow Transplantation.  “Our results indicate that rapid hematopoietic recovery from Gamida Cell’s NiCord transplantation approach is associated with clinical benefit. […]

Filed Under: Clinical Trials, Featured, Oncology, Stem Cells Tagged With: Gamida Cell

Researchers identify signal that could speed up healing

April 19, 2017 By Sarah Faulkner

Regenerated muscle cells

Researchers from the University of Southern California identified the signal that triggers stem cells to take action after an injury and showed how it could be used as a therapy to accelerate the body’s healing process. “Our research shows that by priming the body before an injury, you can speed the process of tissue repair and […]

Filed Under: Featured, Research & Development, Stem Cells Tagged With: universityofsoutherncalifornia

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Interim pages omitted …
  • Page 7
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS